Corcept Therapeutics Incorporated
USE OF GLUCOCORTICOID RECEPTOR MODULATORS TO POTENTIATE CHECKPOINT INHIBITORS
Last updated:
Abstract:
This invention provides a method that combines a checkpoint inhibitor and a glucocorticoid receptor modulator to treat cancer, e.g., a checkpoint inhibitor sensitive cancer.
Status:
Application
Type:
Utility
Filling date:
23 Mar 2021
Issue date:
8 Jul 2021